Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease (FUTURE-SFA)
Randomized Controlled Trial of First Sirolimus Coated Balloon Versus Standard Balloon Angioplasty in The Treatment of Superficial Femoral Artery and Popliteal Artery Disease
Sponsor: Concept Medical Inc.
Listed as NCT04511234, this NA trial focuses on Arterial Disease and Atherosclerosis and remains actively recruiting participants. Sponsored by Concept Medical Inc., it has been updated 13 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Recruiting NA
-
Aug 2025 — Sep 2025 [monthly]
Recruiting NA
-
Sep 2024 — Aug 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Mar 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Sep 2023 — Mar 2024 [monthly]
Recruiting NA
-
Sep 2022 — Sep 2023 [monthly]
Recruiting NA
-
Feb 2022 — Sep 2022 [monthly]
Recruiting NA
-
Sep 2021 — Feb 2022 [monthly]
Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
-
Oct 2020 — Nov 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Concept Medical Inc.
For direct contact, visit the study record on ClinicalTrials.gov .